Technetium-99m Generators

A revolutionary new process to meet the demand for Technetium-99m, currently in development.

Molybdenum-99 (Mo-99) is used to produce Technetium-99 metastable (Tc-99m), one of the most prevalently used diagnostic imaging agents in nuclear medicine to help detect illnesses like cancer and heart disease.

Our scientists and engineers have developed a Tc-99m generator to meet the long-term, stable supply for diagnostic imaging. Featuring a patent-pending neutron capture process, this innovative technology is designed to produce molybdenum-99 (Mo-99), the parent isotope of Technetium-99m (Tc-99m), which is used in over 40 million medical procedures across the globe each year.

What makes our technology different?

Historically, Mo-99 has been produced within research reactors using uranium as a starting material. But our new proprietary technology features:

  • A neutron capture process that will use molybdenum, rather than uranium, targets (mitigating radioactive waste streams and nuclear proliferation concerns)
  • Irradiation of molybdenum targets at commercial power reactors
  • A process to convert low-specific-activity Mo-99 into technetium generators that perform the same as other generators on the market (i.e., offering the same activity, quality, and method of elution)
After receiving FDA approval, Mo-99 produced at Ontario Power Generation’s Darlington Nuclear Generating Station will be processed at our Ottawa facility and incorporated into Tc-99m generators for delivery to radiopharmacies and hospitals across North America.
3D spinning Technitium-99m generator image.


Call 1.800.267.6211 (North America) or 1.613.963.2621 (International).

Watch the Tc-99m Elution Process

BWXT Medical's Tc-99m generators - 3D cutaway.
Play Video

Data Sheet:

This Website Uses Cookies.

We use cookies to give you the best user experience. No personal information is collected in this process.